MMRF CoMMpass Study
Progress Report
SM
Making revolutionary
treatments a reality
The MMRF CoMMpass StudySM
It is critical to provide researchers
over time in a specific patient, allowing
is the organization’s landmark
and clinicians with uninhibited access
healthcare professionals to adjust the
research study in patients with newly
to data. The MMRF breaks down
course of treatment based on a patient’s
diagnosed active multiple myeloma,
traditional barriers that have slowed
unique genetic profile.
and the cornerstone of the MMRF’s
research in the past by sharing data
precision medicine initiative. The goal
with industry and academic partners
About the MMRF Researcher Gateway
is to map the genomic profile of up to
and encouraging them to work together
The MMRF Researcher Gateway is
1,000 myeloma patients at diagnosis,
to accelerate research and cures. We
an information ecosystem designed
and at multiple points throughout
believe the MMRF CoMMpass Study
to make key genomic and clinical data
the course of the disease, helping
will revolutionize the way multiple
from the CoMMpass Study accessible
researchers to understand how
myeloma is treated.
to scientists as they test various
each patient responds to different
treatments over time.
hypothesies with the intention of
Recent Progress
driving discoveries in multiple myeloma.
The fifth data release — or interim
By obtaining an unprecedented level
analysis as you may see it referred
Approximately every six months, we
of clinical and genomic information —
to — occurred in March 2015. This
provide researchers and healthcare
from initial diagnosis for at least eight
release made the genomic data from
professionals with updated data through
years — and then linking this data to
190 participants available on the MMRF
our Researcher Gateway.
patients’ responses to treatment, the
Researcher Gateway.
study will accelerate new and effective
By participating in the MMRF CoMMpass
therapies for patients, and provide
The data also included the first
Study, patients are helping to accelerate
unique information that may also
comparisons of molecular changes that
the next generation of multiple myeloma
lead to the beginning of cures for
occurred at diagnosis and at points of
treatments. Our next data release will
various subtypes.
progression from the same patient.
be available later this summer.
n
This means that researchers will be able to
better understand how myeloma changes
To learn more about the MMRF CoMMpass Study visit themmrf.org/CoMMpass.
10
T HE MMRF.ORG